Osteoarthritis: Pathophysiology

On this page

Osteoarthritis: Pathophysiology - Joint Failure Unveiled

Osteoarthritis (OA) is a progressive "whole joint" disease, not just wear and tear, leading to joint failure.

  • Core Pathology: Progressive loss of articular cartilage.
  • Key Features:
    • Subchondral bone sclerosis & cyst formation.
    • Synovitis (inflammation of synovium).
    • Meniscal degeneration (knee).
    • Ligamentous laxity.
  • Types:
    • Primary OA: Idiopathic, most common, often age-related.
    • Secondary OA: Due to a known cause (e.g., trauma, other arthritis).

⭐ OA is the most common form of arthritis worldwide, affecting millions and a leading cause of disability in the elderly.

Osteoarthritis: Pathophysiology - The Matrix Mission

OA: progressive articular cartilage degradation from chondrocyte dysfunction and extracellular matrix (ECM) breakdown, overwhelming repair.

  • Chondrocyte Dysfunction:
    • Key features: Senescence, apoptosis, altered phenotype (hypertrophic-like).
    • Imbalance: ↑ Catabolic enzymes (MMPs, ADAMTS); ↓ anabolic (matrix synthesis) activity.
  • ECM Degradation:
    • Targets: Collagen type II (structural), Aggrecan (compressive).
    • Enzymes: MMPs (e.g., MMP-13) degrade collagen; ADAMTS (e.g., ADAMTS-5) degrade aggrecan.
  • Failed Repair Mechanisms:
    • Ineffective chondrocyte repair, forms mechanically inferior fibrocartilage.

Cartilage Structural Changes:

  • Early Changes:
    • Fibrillation (superficial cracks/fraying).
    • Swelling (↑ water content, initial ↓ proteoglycans).
  • Late Changes:
    • Erosion (progressive cartilage loss).
    • Eburnation (subchondral bone polished, dense, sclerotic).

⭐ Loss of proteoglycans is an early event leading to increased water content and reduced stiffness in cartilage.

Osteoarthritis Cartilage Degeneration Grades 1-3

Osteoarthritis: Pathophysiology - The Angry Neighbors

  • Subchondral Bone Remodeling: "The stressed foundation."
    • Sclerosis: ↑ bone density beneath cartilage, appears whiter on X-ray.
    • Cysts: Fluid-filled cavities within subchondral bone.
    • Osteophytes: Marginal bony outgrowths; body's attempt to ↑ joint surface area and stabilize.

      ⭐ Osteophytes are attempts at repair and stabilization but can cause pain and restrict motion.

    • Bone marrow lesions (BMLs): Associated with pain, reflect inflammation/edema.
  • Synovitis: The Inflamed Lining: "Low-grade, chronic fire."
    • Synovial hypertrophy and low-grade inflammation.
    • Key pro-inflammatory cytokines: Interleukin-1β (IL-1β), Tumor Necrosis Factor-α (TNF-α), Interleukin-6 (IL-6).
    • Innate immune cells, especially macrophages, contribute to inflammation.
  • Cartilage-Bone-Synovium Crosstalk: "A dysfunctional neighborhood."
    • A complex interplay: damage in one tissue (cartilage, bone, synovium) affects others.
    • Cartilage degradation products (e.g., fibronectin fragments) trigger synovial inflammation.
    • Synovium releases catabolic enzymes (MMPs) and cytokines, further damaging cartilage and bone.
    • Altered subchondral bone mechanics impact overlying cartilage integrity. Normal vs OA Joint Changes

Osteoarthritis: Pathophysiology - The Destructive Orchestra

Osteoarthritis (OA) features progressive articular cartilage loss from an imbalance between destructive and reparative processes, orchestrated by molecular mediators and key risk factors.

  • Key Molecular Mediators:

    • Enzymes (Catabolic):
      • Matrix Metalloproteinases (MMPs): MMP-1, MMP-3, MMP-13 (collagenase-3) degrade Type II collagen.
      • ADAMTS (Aggrecanases): ADAMTS-4, ADAMTS-5 cleave aggrecan.
    • Pro-inflammatory Cytokines: IL-1β, TNF-α drive inflammation and matrix degradation.
    • Chemokines: Attract inflammatory cells to the joint.
    • Growth Factors: TGF-β exhibits a complex role (repair vs. fibrosis).
  • Influential Risk Factors:

    • Age: Associated with chondrocyte senescence and ↓ repair capacity.
    • Obesity: ↑ Mechanical stress + metabolic inflammation via adipokines (e.g., leptin).
    • Genetics: e.g., mutations in collagen genes (COL2A1), GDF5.
    • Trauma/Joint Injury: Initiates degenerative changes (post-traumatic OA).
    • Mechanical Stress/Malalignment: Leads to abnormal joint load distribution.

Osteoarthritis Pathophysiology and Risk Factors

MMP-13 (collagenase-3) is a key enzyme responsible for Type II collagen degradation in OA.

High‑Yield Points - ⚡ Biggest Takeaways

  • Articular cartilage degradation is the hallmark, driven by chondrocyte dysfunction and an imbalance in matrix synthesis and breakdown.
  • Key enzymes like Matrix Metalloproteinases (MMPs) and ADAMTS degrade collagen type II and aggrecan.
  • Subchondral bone sclerosis, cyst formation, and marginal osteophyte development are characteristic structural changes.
  • Low-grade synovial inflammation (synovitis), mediated by cytokines like IL-1β and TNF-α, contributes to pain and progression.
  • Mechanical stress, aging, genetics, and obesity are significant risk factors.
  • Progressive loss of cartilage integrity leads to joint space narrowing and functional impairment.
  • Chondrocyte apoptosis and altered signaling pathways further exacerbate cartilage damage.

Practice Questions: Osteoarthritis: Pathophysiology

Test your understanding with these related questions

Osteoarthritis is associated with all of the following except -

1 of 5

Flashcards: Osteoarthritis: Pathophysiology

1/10

What is the earliest pathological change seen in osteoarthritis?_____

TAP TO REVEAL ANSWER

What is the earliest pathological change seen in osteoarthritis?_____

Asymmetrical hyaline articular cartilage loss

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial